HELIXOR A Ampoules 30 mg, 50 pcs

Instructions for use of Helixor A 30 mg

No prescription is required for this product.

Active ingredient and composition

Helixor A contains an extract of fresh pine mistletoe (Viscum album ssp. abietis) in a ratio of 1:20.The solution for injection is prepared with water for injections and sodium chloride (99.91:0.09).One ampoule corresponds to 30 mg of fresh plant.The preparation also contains sodium hydroxide and water for injections.

Areas of application

Helixor A is used according to the anthroposophical knowledge of humanity and nature.In adults, these include:

• Malignant and benign tumor diseases

• Malignant diseases of the blood-forming organs

• Defined precancerous lesions

• Prevention of relapses after tumor operations

Application and dosage

Helixor A is administered as a subcutaneous injection, if possible close to the tumor or in different areas of the intact skin.The usual dosage is 2-3 injections per week.Therapy begins with a low dose, which is gradually increased until the optimal individual dose is reached.Dose adjustment may be necessary during radiation or chemotherapy.

The optimal dose is determined individually and depends on reactions such as subjective well-being, temperature reaction, immunological reaction and local inflammatory reaction at the injection site.In the event of an overdose, excessive inflammatory reactions may occur, which can be treated with moist cool compresses or anti-inflammatory ointments.

Side effects and precautions

Possible side effects include a slight increase in body temperature, localized inflammatory reactions around the injection site, and temporary mild swelling of regional lymph nodes.If there is a fever over 38 °C or major local reactions over 5 cm in diameter, the next injection should only be given after these symptoms have subsided and at a reduced strength or dose.

Helixor A must not be used in cases of hypersensitivity to mistletoe preparations, acute inflammatory or high fever diseases, chronic granulomatous diseases and autoimmune diseases with severe symptoms, under immunosuppressive treatment or in cases of hyperthyroidism with palpitations.

Particular caution is required in the case of hypersensitivity to other substances, primary brain and spinal cord tumors or intracranial metastases with a risk of increased intracranial pressure.

Storage

Helixor A should be kept out of the reach of children and should not be used after the expiry date.The ampoules should be stored in the refrigerator in their original packaging to protect the contents from light.

Contents of the pack

Helixor A is available in original packs of 8 ampoules of the same concentration (0.01-100 mg) and in serial packs of 7 ampoules in increasing concentrations.The series packs include various combinations of ampoules with different concentrations.